SCHEMBL6480557

SCHEMBL6480557

OC/C=C/Cc1ccc(-c2ccc(Br)cc2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 1/20 0.38
MAOB P27338 1/20 0.38
IDO1 P14902 4/20 0.38
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
LSS P48449 2/20 0.35
HTR2A P28223 1/20 0.34
TAAR1 Q96RJ0 1/20 0.34
MME P08473 1/20 0.34
TGM2 P21980 1/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
PRNP P04156 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
HAO1 Q9UJM8 1/20 0.33
GPR52 Q9Y2T5 1/20 0.33
KIF11 P52732 1/20 0.33
CYP2A6 P11509 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6480564 1.00 ALDH1A1 (0.38) ALDH1A1MAPK1MAOBIDO1MEN1
SCHEMBL11879390 0.82 MAOB (0.56) ALDH1A1MAOBIDO1MEN1KMT2A
SCHEMBL9680305 0.74 ALDH1A1 (0.44) ALDH1A1MAPK1IDO1MEN1KMT2A
SCHEMBL7671397 0.74 IDO1 (0.42) IDO1MEN1KMT2AHTR2ATAAR1
SCHEMBL24042960 0.74 IDO1 (0.43) MAOBIDO1MEN1KMT2AHTR2A
SCHEMBL28039769 0.74 IDO1 (0.43) MAOBIDO1MEN1KMT2AHTR2A
SCHEMBL6231872 0.74 MAOB (0.71) ALDH1A1MAPK1MAOBIDO1HTR2A
SCHEMBL3255735 0.74 IDO1 (0.43) MAOBIDO1MEN1KMT2AHTR2A
SCHEMBL3865773 0.73 ALDH1A1 (0.48) ALDH1A1MAPK1IDO1HTR2ATAAR1
SCHEMBL11200333 0.72 MAOB (0.42) ALDH1A1MAPK1MAOBIDO1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869967-B2 Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives NOVO NORDISK A/S (DK) 2005-03-22 US disclosed
EP-1414778-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC. NOVO NORDISK A/S (DK) 2004-05-06 EP disclosed
US-20030139473-A1 Novel compounds, their preparation and use VTVX HOLDINGS II LLC 2003-07-24 US disclosed
WO-2003011807-A1 NOVEL VINYL CARBOXYLIC ACID DERIVATIVES AND THEIR USE AS ANTIDIABETICS ETC. NOVO NORDISK A/S (DK) 2003-02-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139473-A1 Novel compounds, their preparation and use PPARG, PPARD, PPARA ALDH1A1 722/4885MAPK1 2460/4885MAOB 1897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.